Literature DB >> 11878305

Incidence and natural history of Paget's disease of bone in England and Wales.

T P van Staa1, P Selby, H G M Leufkens, K Lyles, J M Sprafka, C Cooper.   

Abstract

This study used a large, primary care, record-linkage resource (the General Practice Research Database [GPRD]) to evaluate the incidence, clinical presentation, and natural history of Paget's disease of bone in England and Wales. Between 1988 and 1999, we identified 2465 patients with the recorded diagnosis of Paget's disease of bone, within the five million subjects > or = 18 years old who were registered in the GPRD. The validity of diagnostic recording was assessed by questionnaire to individual general practitioners (GPs) in 150 patients; the diagnosis was confirmed in 93.8% of responders. The mean age of patients with Paget's disease was 75 years and 51% were men. The prevalence of the disorder was 0.3% among men and women aged > or = 55 years; incidence rates for clinically diagnosed Paget's disease rose steeply with age (men, 5 per 10,000 person-years; women, 3 per 10,000 person-years at the age of 75 years). Over the 11-year period of the study, the age- and sex-adjusted incidence rate of clinically diagnosed Paget's disease declined from 1.1 per 10,000 person-years to 0.7 per 10,000 person-years. Each patient with Paget's disease was matched to three controls matched by age, gender, and general practice. Cases had a greater risk of back pain (relative risk [RR], 2.1; 95% CI, 1.9-2.3), osteoarthritis (OA; RR, 1.7; 95% CI, 1.5-1.9), hip arthroplasty (RR, 3.1; 95% CI, 2.4-4.1), knee arthroplasty (RR, 1.6; 95% CI, 1.0-2.6), fracture (RR, 1.2; 95% CI, 1.0-1.5), and hearing loss (RR, 1.6; 95% CI, 1.3-1.9). Seven patients with Paget's disease developed a malignant bone neoplasm (0.3%). Using life table methodology, the estimated number of people who died within 5 years of follow-up was 32.7% among the patients with Paget's disease and 28.0% among the control patients.

Entities:  

Mesh:

Year:  2002        PMID: 11878305     DOI: 10.1359/jbmr.2002.17.3.465

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  67 in total

Review 1.  Cellular and molecular biology of optineurin.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.

Authors:  Pui Yan Jenny Chung; Greet Beyens; Steven Boonen; Socrates Papapoulos; Piet Geusens; Marcel Karperien; Filip Vanhoenacker; Leon Verbruggen; Erik Fransen; Jan Van Offel; Stefan Goemaere; Hans-Georg Zmierczak; René Westhovens; Jean-Pierre Devogelaer; Wim Van Hul
Journal:  Hum Genet       Date:  2010-09-14       Impact factor: 4.132

3.  Active Paget's disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature.

Authors:  Lamprini Gkouva; Maria Andrikoula; Vasilis Kontogeorgakos; Dionysios J Papachristou; Agathocles Tsatsoulis
Journal:  Clin Rheumatol       Date:  2010-10-01       Impact factor: 2.980

Review 4.  The fracture mechanics of human bone: influence of disease and treatment.

Authors:  Elizabeth A Zimmermann; Björn Busse; Robert O Ritchie
Journal:  Bonekey Rep       Date:  2015-09-02

5.  The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget's Disease in a United States Cohort.

Authors:  Margaret Seton; Marc Hansen; Daniel H Solomon
Journal:  Calcif Tissue Int       Date:  2015-12-28       Impact factor: 4.333

Review 6.  Paget disease of bone.

Authors:  G David Roodman; Jolene J Windle
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

7.  Prevalence and clinical features of Paget's disease of bone in Japan.

Authors:  Jun Hashimoto; Ikko Ohno; Kiyoshi Nakatsuka; Noriko Yoshimura; Shinjiro Takata; Masaaki Zamma; Hiroo Yabe; Satoshi Abe; Masaki Terada; Kousei Yoh; Masao Fukunaga; Cyrus Cooper; Hirotoshi Morii; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

8.  Is Paget's disease of bone disappearing?

Authors:  T Cundy
Journal:  Skeletal Radiol       Date:  2006-06       Impact factor: 2.199

9.  Guidelines for diagnosis and management of Paget's disease of bone in Japan.

Authors:  Shinjiro Takata; Jun Hashimoto; Kiyoshi Nakatsuka; Noriko Yoshimura; Kousei Yoh; Ikko Ohno; Hiroo Yabe; Satoshi Abe; Masao Fukunaga; Masaki Terada; Masaaki Zamma; Stuart H Ralston; Hirotoshi Morii; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

10.  Decreasing severity of Paget's disease of bone in northern Italy over the last two decades: results of a monocentric study on 391 patients.

Authors:  M Varenna; F Zucchi; C Crotti; M Manara; R Caporali
Journal:  Osteoporos Int       Date:  2021-02-22       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.